Mr.Rolf Frei, the Director of Trade Office of Swiss Industries said Switzerland invests more than 3% of its GDP in research and development. Strong cooperation with universities, the presence of multinational companies, good financial system and strong IP protection are some factors that contribute to the success of biotechnology in Switzerland. Innovation, Mr.Rolf Frei, said is the driving force behind competitiveness adding that the Swiss government grants funds for special projects submitted by universities and private companies.